Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
134.75
+0.04 (0.03%)
At close: Aug 20, 2026, 4:00 PM EDT
134.73
-0.02 (-0.01%)
Pre-market: Aug 21, 2026, 8:06 AM EDT
Apogee Therapeutics Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, Apogee Therapeutics stock has a consensus rating of "Hold" and an average price target of $134.85. The average 1-year stock price forecast is 0.07% higher than the current stock price, while the lowest is $133 (-1.30%) and the highest is $135.11 (+0.27%).
Price Target: $134.85 (+0.07%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Apogee Therapeutics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 14 | 14 | 15 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 4 | 13 | 13 | 14 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 19 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citi | Citi | Hold Maintains $135 | Hold | Maintains | $135 | +0.19% | Aug 13, 2026 |
| Truist Financial | Truist Financial | Hold Maintains $81 → $135 | Hold | Maintains | $81 → $135 | +0.19% | Aug 13, 2026 |
| Canaccord Genuity | Canaccord Genuity | Hold Reiterates $135 | Hold | Reiterates | $135 | +0.27% | Aug 11, 2026 |
| Wedbush | Wedbush | Hold Maintains $135 | Hold | Maintains | $135 | +0.19% | Aug 11, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $135 | Hold | Maintains | $135 | +0.19% | Aug 10, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
11.54M
EPS This Year
-4.75
from -4.22
EPS Next Year
-5.23
from -4.75
EPS and Forward PE are based on non-GAAP adjusted numbers.